Hi Carl,
I’m 48 and have an 11yr old boy and like you, it’s my intention to be around for as long as possible to see him grow up! Hopefully I can do that whilst living as ‘normal’ a life as possible as well. I chose Brachy in the hope that it will tick both boxes satisfactorily.
Time will tell whether I’ve been overly optimistic but regardless of what the future holds, when diagnosed as we’ve been, at an early stage and with a low (low/intermediate for me) grade, I couldn’t really see any differences between the curative outcomes of Brachy or RARP as a primary treatment.
Despite the popular consensus being that RARP would be the path of least regret for us young men, I just couldn’t reconcile the fairly significant increased risk of side effects and recovery time that was associated with RARP when the likelihood of success with Brachy was virtually identical.
The consultant who did my procedure said that when he started doing Brachy more than 20 years ago, he thought 10% of his patients (all grades/stages) might fail the treatment and require salvage treatment. In fact, 2000 procedures later he’s had less than 30 patients suffer failure – that’s just 1.5% of all cases over 20+ years! He also made the point that 20 years ago, the quality of the procedure and the dosimetry of the implants was far inferior to today’s techniques.
Another oncologist at a different facility said he and another colleague had also done more than 2000 procedures over nearly 20 years and their failure rate in that time was less than 8%. This second oncologist also said that he didn’t believe any of those failures was because a 2nd independent cancer had developed further down the line but rather that the failure was because the initial treatment hadn’t succeeded in killing the original cancer and that then caused future biochemical failure. The key then, is whether the initial treatment is successful and not whether a new cancer will subsequently develop in the prostate that has been left behind.
Someone posted this link ( https://www.youtube.com/watch?v=jY9oZ6iiVq4 ) in another thread which I thought was very interesting and reiterates a lot of what I heard when meeting with the different oncologists.
So yes, there’s no doubt if Brachy fails to cure the primary cancer then salvage is difficult – more difficult than after RARP and probably always with worse side effects but that doesn’t mean salvage after failed RARP is a cakewalk either - it too can result in significant problems. Conversely though, if it works, Brachy is likely to leave you with far fewer side effects and a better QoL.
Some of the best advice I felt I was given was to try not to focus too much on the ‘what if it fails’ question but instead focus on the ‘how likely is each treatment going to be at curing what I have now?’ question.
It’s still a shocking decision to be faced with though and although it’s probably inevitable that I’ve come across as being Brachy biased because that’s the path I recently chose, I really don’t mean to try to influence anyone – I just want to try and pass on some of the more pertinent information I gleaned when trying to make a decision.
It was definitely the hardest decision I’ve ever had to make and I lost count of the number of times I changed my mind during the process - whatever you decide, I wish you the very best of luck and a long and healthy future life.
Cheers, Paul